Overview

Erythropoietin Spinal Cord Compression Randomized Trial

Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To determine whether erythropoietin, steroids and radiotherapy is safe and feasible to administer to patients with malignant spinal cord compression.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborator:
Ortho Biotech, Inc.
Treatments:
Epoetin Alfa